共 50 条
- [3] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration [J]. International Journal of Retina and Vitreous, 7
- [4] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development [J]. OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
- [8] Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration A Prospective Study [J]. OPHTHALMOLOGY RETINA, 2020, 4 (08): : 767 - 776
- [9] Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients [J]. THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
- [10] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192